The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable

David S Knopman, Samantha Budd Haeberlein, Maria C. Carrillo, James A. Hendrix, Geoff Kerchner, Richard Margolin, Paul Maruff, David S. Miller, Gary Tong, Maria B. Tome, Melissa E Murray, Peter T. Nelson, Mary Sano, Niklas Mattsson, David L. Sultzer, Thomas J. Montine, Clifford R Jr. Jack, Hartmuth Kolb, Ronald Carl Petersen, Prashanthi D VemuriMegan Zoschg Canniere, Julie A. Schneider, Susan M. Resnick, Gary Romano, Argonde Corien van Harten, David A. Wolk, Lisa J. Bain, Eric Siemers

Research output: Contribution to journalShort survey

21 Citations (Scopus)

Abstract

The Alzheimer's Association's Research Roundtable met in November 2017 to explore the new National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease. The meeting allowed experts in the field from academia, industry, and government to provide perspectives on the new National Institute on Aging and the Alzheimer's Association Research Framework. This review will summarize the “A, T, N System” (Amyloid, Tau, and Neurodegeneration) using biomarkers and how this may be applied to clinical research and drug development. In addition, challenges and barriers to the potential adoption of this new framework will be discussed. Finally, future directions for research will be proposed.

Original languageEnglish (US)
Pages (from-to)563-575
Number of pages13
JournalAlzheimer's and Dementia
Volume14
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

National Institute on Aging (U.S.)
Alzheimer Disease
Research
Amyloid
Industry
Biomarkers
Pharmaceutical Preparations

Keywords

  • Alzheimer's disease
  • Amyloid
  • Biomarkers
  • Clinical trials
  • Neurodegeneration
  • Tau

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease : Perspectives from the Research Roundtable. / Knopman, David S; Haeberlein, Samantha Budd; Carrillo, Maria C.; Hendrix, James A.; Kerchner, Geoff; Margolin, Richard; Maruff, Paul; Miller, David S.; Tong, Gary; Tome, Maria B.; Murray, Melissa E; Nelson, Peter T.; Sano, Mary; Mattsson, Niklas; Sultzer, David L.; Montine, Thomas J.; Jack, Clifford R Jr.; Kolb, Hartmuth; Petersen, Ronald Carl; Vemuri, Prashanthi D; Canniere, Megan Zoschg; Schneider, Julie A.; Resnick, Susan M.; Romano, Gary; van Harten, Argonde Corien; Wolk, David A.; Bain, Lisa J.; Siemers, Eric.

In: Alzheimer's and Dementia, Vol. 14, No. 4, 01.04.2018, p. 563-575.

Research output: Contribution to journalShort survey

Knopman, DS, Haeberlein, SB, Carrillo, MC, Hendrix, JA, Kerchner, G, Margolin, R, Maruff, P, Miller, DS, Tong, G, Tome, MB, Murray, ME, Nelson, PT, Sano, M, Mattsson, N, Sultzer, DL, Montine, TJ, Jack, CRJ, Kolb, H, Petersen, RC, Vemuri, PD, Canniere, MZ, Schneider, JA, Resnick, SM, Romano, G, van Harten, AC, Wolk, DA, Bain, LJ & Siemers, E 2018, 'The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable', Alzheimer's and Dementia, vol. 14, no. 4, pp. 563-575. https://doi.org/10.1016/j.jalz.2018.03.002
Knopman, David S ; Haeberlein, Samantha Budd ; Carrillo, Maria C. ; Hendrix, James A. ; Kerchner, Geoff ; Margolin, Richard ; Maruff, Paul ; Miller, David S. ; Tong, Gary ; Tome, Maria B. ; Murray, Melissa E ; Nelson, Peter T. ; Sano, Mary ; Mattsson, Niklas ; Sultzer, David L. ; Montine, Thomas J. ; Jack, Clifford R Jr. ; Kolb, Hartmuth ; Petersen, Ronald Carl ; Vemuri, Prashanthi D ; Canniere, Megan Zoschg ; Schneider, Julie A. ; Resnick, Susan M. ; Romano, Gary ; van Harten, Argonde Corien ; Wolk, David A. ; Bain, Lisa J. ; Siemers, Eric. / The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease : Perspectives from the Research Roundtable. In: Alzheimer's and Dementia. 2018 ; Vol. 14, No. 4. pp. 563-575.
@article{c21c4a70bf92426fa901e5d279e1d33d,
title = "The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable",
abstract = "The Alzheimer's Association's Research Roundtable met in November 2017 to explore the new National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease. The meeting allowed experts in the field from academia, industry, and government to provide perspectives on the new National Institute on Aging and the Alzheimer's Association Research Framework. This review will summarize the “A, T, N System” (Amyloid, Tau, and Neurodegeneration) using biomarkers and how this may be applied to clinical research and drug development. In addition, challenges and barriers to the potential adoption of this new framework will be discussed. Finally, future directions for research will be proposed.",
keywords = "Alzheimer's disease, Amyloid, Biomarkers, Clinical trials, Neurodegeneration, Tau",
author = "Knopman, {David S} and Haeberlein, {Samantha Budd} and Carrillo, {Maria C.} and Hendrix, {James A.} and Geoff Kerchner and Richard Margolin and Paul Maruff and Miller, {David S.} and Gary Tong and Tome, {Maria B.} and Murray, {Melissa E} and Nelson, {Peter T.} and Mary Sano and Niklas Mattsson and Sultzer, {David L.} and Montine, {Thomas J.} and Jack, {Clifford R Jr.} and Hartmuth Kolb and Petersen, {Ronald Carl} and Vemuri, {Prashanthi D} and Canniere, {Megan Zoschg} and Schneider, {Julie A.} and Resnick, {Susan M.} and Gary Romano and {van Harten}, {Argonde Corien} and Wolk, {David A.} and Bain, {Lisa J.} and Eric Siemers",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.jalz.2018.03.002",
language = "English (US)",
volume = "14",
pages = "563--575",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease

T2 - Perspectives from the Research Roundtable

AU - Knopman, David S

AU - Haeberlein, Samantha Budd

AU - Carrillo, Maria C.

AU - Hendrix, James A.

AU - Kerchner, Geoff

AU - Margolin, Richard

AU - Maruff, Paul

AU - Miller, David S.

AU - Tong, Gary

AU - Tome, Maria B.

AU - Murray, Melissa E

AU - Nelson, Peter T.

AU - Sano, Mary

AU - Mattsson, Niklas

AU - Sultzer, David L.

AU - Montine, Thomas J.

AU - Jack, Clifford R Jr.

AU - Kolb, Hartmuth

AU - Petersen, Ronald Carl

AU - Vemuri, Prashanthi D

AU - Canniere, Megan Zoschg

AU - Schneider, Julie A.

AU - Resnick, Susan M.

AU - Romano, Gary

AU - van Harten, Argonde Corien

AU - Wolk, David A.

AU - Bain, Lisa J.

AU - Siemers, Eric

PY - 2018/4/1

Y1 - 2018/4/1

N2 - The Alzheimer's Association's Research Roundtable met in November 2017 to explore the new National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease. The meeting allowed experts in the field from academia, industry, and government to provide perspectives on the new National Institute on Aging and the Alzheimer's Association Research Framework. This review will summarize the “A, T, N System” (Amyloid, Tau, and Neurodegeneration) using biomarkers and how this may be applied to clinical research and drug development. In addition, challenges and barriers to the potential adoption of this new framework will be discussed. Finally, future directions for research will be proposed.

AB - The Alzheimer's Association's Research Roundtable met in November 2017 to explore the new National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease. The meeting allowed experts in the field from academia, industry, and government to provide perspectives on the new National Institute on Aging and the Alzheimer's Association Research Framework. This review will summarize the “A, T, N System” (Amyloid, Tau, and Neurodegeneration) using biomarkers and how this may be applied to clinical research and drug development. In addition, challenges and barriers to the potential adoption of this new framework will be discussed. Finally, future directions for research will be proposed.

KW - Alzheimer's disease

KW - Amyloid

KW - Biomarkers

KW - Clinical trials

KW - Neurodegeneration

KW - Tau

UR - http://www.scopus.com/inward/record.url?scp=85044929982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044929982&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2018.03.002

DO - 10.1016/j.jalz.2018.03.002

M3 - Short survey

C2 - 29653607

AN - SCOPUS:85044929982

VL - 14

SP - 563

EP - 575

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

IS - 4

ER -